Sam-A Pharm. Co. Ltd Asset Resilience Ratio
Sam-A Pharm. Co. Ltd asset resilience ratio. Sam-A Pharm. Co. Ltd (009300) has an Asset Resilience Ratio of 36.86% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 009300 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Sam-A Pharm. Co. Ltd (2009–2025)
Asset resilience ratio of Sam-A Pharm. Co. Ltd from 2009 to 2025. This chart shows how Sam-A Pharm. Co. Ltd's Asset Resilience Ratio has changed over time. Read Sam-A Pharm. Co. Ltd (009300) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Sam-A Pharm. Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Sam-A Pharm. Co. Ltd total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩91.06 Billion | 36.86% |
| Total Liquid Assets | ₩91.06 Billion | 36.86% |
Asset Resilience Insights
- Very High Liquidity: Sam-A Pharm. Co. Ltd maintains exceptional liquid asset reserves at 36.86% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Sam-A Pharm. Co. Ltd Industry Peers by Asset Resilience Ratio
Compare Sam-A Pharm. Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GeneBioTech Co. Ltd
KQ:086060 |
Pharmaceuticals | 22.68% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 6.87% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 66.73% |
|
Komipharm International Co. Ltd
KQ:041960 |
Pharmaceuticals | 0.00% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 0.00% |
|
Aprogen Healthcare & Games Inc
KQ:109960 |
Pharmaceuticals | 6.55% |
Sam-A Pharm. Co. Ltd Asset Resilience Ratio by Year (2009–2025)
Sam-A Pharm. Co. Ltd asset resilience ratio by year from 2009 to 2025. The table below shows the annual Asset Resilience Ratio data for Sam-A Pharm. Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 36.86% | ₩91.06 Billion ≈ $61.71 Million |
₩247.04 Billion ≈ $167.42 Million |
+9.12pp |
| 2024-12-31 | 27.74% | ₩68.99 Billion ≈ $46.76 Million |
₩248.73 Billion ≈ $168.56 Million |
-6.46pp |
| 2023-12-31 | 34.20% | ₩79.10 Billion ≈ $53.61 Million |
₩231.31 Billion ≈ $156.75 Million |
-3.88pp |
| 2022-12-31 | 38.07% | ₩77.37 Billion ≈ $52.43 Million |
₩203.20 Billion ≈ $137.70 Million |
+10.07pp |
| 2021-12-31 | 28.01% | ₩52.98 Billion ≈ $35.90 Million |
₩189.17 Billion ≈ $128.20 Million |
-7.09pp |
| 2020-12-31 | 35.09% | ₩63.91 Billion ≈ $43.31 Million |
₩182.11 Billion ≈ $123.41 Million |
+18.46pp |
| 2019-12-31 | 16.63% | ₩31.73 Billion ≈ $21.50 Million |
₩190.78 Billion ≈ $129.29 Million |
-8.69pp |
| 2018-12-31 | 25.32% | ₩43.99 Billion ≈ $29.81 Million |
₩173.69 Billion ≈ $117.70 Million |
-1.71pp |
| 2017-12-31 | 27.04% | ₩45.41 Billion ≈ $30.77 Million |
₩167.97 Billion ≈ $113.83 Million |
+3.73pp |
| 2016-12-31 | 23.30% | ₩37.81 Billion ≈ $25.63 Million |
₩162.27 Billion ≈ $109.97 Million |
+9.45pp |
| 2015-12-31 | 13.85% | ₩21.18 Billion ≈ $14.35 Million |
₩152.91 Billion ≈ $103.62 Million |
-8.19pp |
| 2014-12-31 | 22.04% | ₩32.15 Billion ≈ $21.79 Million |
₩145.86 Billion ≈ $98.85 Million |
-3.93pp |
| 2012-12-31 | 25.97% | ₩37.61 Billion ≈ $25.49 Million |
₩144.79 Billion ≈ $98.12 Million |
+10.01pp |
| 2011-12-31 | 15.96% | ₩22.00 Billion ≈ $14.91 Million |
₩137.86 Billion ≈ $93.43 Million |
+10.68pp |
| 2010-12-31 | 5.28% | ₩6.79 Billion ≈ $4.60 Million |
₩128.75 Billion ≈ $87.25 Million |
+1.83pp |
| 2009-12-31 | 3.45% | ₩3.83 Billion ≈ $2.60 Million |
₩111.10 Billion ≈ $75.29 Million |
-- |
About Sam-A Pharm. Co. Ltd
Sam-A Pharm. Co., Ltd operates as a pharmaceutical company in South Korea. The company offers a range of pharmaceutical products in the areas of respiratory, anti-biotics, anti-virals, anti-histamines, anti-fungals, dermatology, pain/inflammation, gastrointestinal, cardiovascular, metabolism, urological, and steroids, as well as psychotropic agents; and OTC products in the areas of respiratory, a… Read more